Anesthetic Management in Perioperative Period

© 2022 by the authors; CC BY-NC-ND license

impedance cardiography (ICG); fasting; enhanced recovery after surgery (ERAS); hemodynamics; cardiac index (CI); systemic vascular resistance index (SVRI); pre-op; perioperative patient management; NICCOMO; methylene blue; vasoplegic syndrome; vasoplegia; shock; cardiac anesthesia; vasopressin; cardiac surgery; cardiopulmonary bypass; postoperative pain; postoperative recovery; epidural analgesia; intrathecal analgesia; erector spinae plane block; lung surgery; video-assisted thoracic surgery; thoracotomy; one-lung ventilation; diffusing capacity for carbon monoxide; iloprost; oxygenation; total knee replacement; arthroplasty; tourniquet; transfusion; vital stability; catecholamines; supplemental oxygen; major abdominal surgery; cardiovascular risk; MINS; supplemental oxygen; perioperative stress; Copeptin; MINS; major abdominal surgery; cardiovascular risk; McGrath; videolaryngoscope; nasotracheal intubation; dexmedetomidine; pain; inflammation; hysterectomy; magnesium; multiple trauma; spectroscopy; near-infrared; cerebral oxygen saturation; neuroprotection; traumatic brain injury; analgesia; opioid consumption; TIVA; total intravenous anaesthesia; volatile anaesthesia; anaesthetic techniques; peri-operative anaesthesia; central venous catheters; echocardiography; left subclavian vein; superior vena cava; ultrasound; bimaxillary surgery; airway complications; risk factors; extubation; pulse wave transit time; ambulatory monitoring; hemodynamic monitoring; local anesthetics; general anesthesia; cerebral tissue oxygen saturation; near-infrared spectroscopy; emergence; thyromental height test; laryngoscopy; airway management; systematic review; meta-analysis; fast-and-frugal decision trees; postoperative outcomes; postoperative delirium; clinical data prediction; medical decision making; arthroplasty; chloroprocaine; perioperative outcome; spinal anaesthesia; dexmedetomidine; midazolam; STOP BANG questionnaire; intraoperative complications; spinal anesthesia; sedation; obstructive sleep apnea; transurethral resection of bladder; transurethral resection of prostate; postoperative pain; fibula free flap; ropivacaine infiltration; local anesthetic toxicity; sevoflurane; cancer-free survival; oncology; anesthesia; TIVA; volatile anesthetics; infective endocarditis; organ failure; cell salvage; blood transfusion; opioid free anesthesia; opioid reduced anesthesia; dexmedetomidine; cervicofacial oncologic surgery; transcranial doppler; postoperative cognitive dysfunction; robotic-assisted prostatectomy; volatile anesthetics; sedation; intensive care unit; mechanical ventilation; isoflurane; sevoflurane; desflurane; von Willebrand factor; ristocetin; endothelial demage; noncardiac surgery; frailty; sarcopenia; hip fracture; psoas muscle; older adult patients; hypotension; association analysis; critical care; correlations; LGEA; MRI; neurology; pediatrics; ultrasound; sonography; arterial catheterization; invasive blood pressure monitoring; coronary stents; noncardiac surgery; troponin I; stent to surgery time interval; Neuromuscular blockade reversals; neostigmine; residual neuromuscular blockade; neuromuscular scoliosis; anesthesia; total intravenous anesthesia; children; spondylosurgery; spine; hip fracture; anesthesia; postoperative outcomes; propensity score; morbidity; mortality; muscle weakness; muscle strength dynamometer; complications; nerve block; quadratus lumborum block; robot-assisted surgery; intravenous infusion; fluid management; surgical procedures; hepatectomy; adverse effects; blepharoplasty; dexmedetomidine; conscious sedation; hematoma; aesthetic surgery; loco-regional anesthesia; rebound pain; dexamethasone; ambulatory surgery